A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Mechanically isolated stromal vascular fraction (SVF) in combination with a fibrin hydrogel offers an easy and efficient carrier for viable adipose-derived stromal cells for various indications, including tissue engineering and or wound healing purposes. Here, we present the preparation of a mechanical SVF (mSVF)-fibrin hydrogel construct for translational research and clinical application.
The regenerative potential of adipose-derived stromal cells (ASCs) has gained significant attention in regenerative and translational research. In the past, the extraction of these cells from adipose tissue required a multistep enzyme-based process, resulting in a heterogenous cell mix consisting of ACSs and other cells, which are jointly termed the stromal vascular fraction (SVF). More recently introduced mechanical SVF (mSVF) isolation protocols are less time-consuming and bypass regulatory concerns. We recently proposed a protocol that generates mSVF rich in stromal cells based on a combination of emulsification and centrifugation. One current issue in mSVF application for wound therapy application is the lack of a scaffold providing protection from mechanical manipulation and desiccation. Fibrin hydrogels have been shown to be a useful adjunct in cell transfer for wound healing purposes in the past. In the work herein, we delineate the preparation steps of an mSVF-fibrin hydrogel construct as a novel approach for translational research and clinical application.
Over the past few years, regenerative plastic surgery has emerged as an additional pillar of plastic surgery1. Regenerative plastic surgery aims to restore damaged tissue by transferring soluble factors, cells, and tissue harvested from the patient to promote tissue restoration in a minimally invasive manner2. Adipose-derived stem cells (ASCs) have gained attention due to their ability to differentiate into multiple mesenchymal lineages, making them a promising candidate for regenerative medicine research3. Their cytokine profile displays angiogenic, immunosuppressive, and an....
This study was performed in accordance with the Declaration of Helsinki. All adult donors provided written informed consent to allow further use of the collected tissue samples. The protocol follows the guidelines of our institution's human research ethics committee.
1. Harvest of adipose tissue
Resazurin assay
We first examined the in vitro cell viability of the mSVF cells. For this purpose, we conducted a resazurin cell viability assay on days 0, 3, and 7. The cell viability at days 0, 3, and 7 of a total of four samples are shown in Figure 1. The values of day 0 serve as the baseline and were set as 100%. At day 3, the positive control (mSVF) showed a slight decrease to 78.92% (± 5.33%), while the mSVF-fibrin hydrogel combination remained at 9.......
The mechanical isolation of SVF provides an elegant alternative to the traditional enzymatic approach and offers broad access for clinical application29. In fact, mSVF, as proposed in the present manuscript, is already in clinical use for soft tissue treatment of scars or as an adjunct for cosmetic procedures30. The protocol presented here provides a simple method for efficient topical delivery of viable mSVF cells. While the positive control with only mSVF cells showed a t.......
The authors have nothing to disclose.
Bong-Sung Kim is supported by the German Research Foundation (KI 1973/2-1) and the Novartis Foundation for Medical-Biological Research (#22A046).
....Name | Company | Catalog Number | Comments |
12-Wellplate | Sarstedt | 83.3921 | |
4′,6-diamidino-2-phenylindole (DAPI) | Biochemica | A1001.0010 | |
50 mL-Falcon | Falcon | 352070 | |
Absorbent Towels, Two Pack | Halyard | 89701 | |
Alamar blue 25 mL | Invitrogen | DAL1025 | |
Albumin, Bovine (BSA) | VWR | 0332-500G | |
Biotek Cytation 5 | Agilent | Cell Imaging Multimode Microplate Reader | |
CaCl2 | Sigma-Aldrich | C5670-500G | |
Cryostat | Microtome | ||
DMEM with 4,5 g/L glucose,with L-Glutamine, with sodium pyruvate | VWR | 392-0416 | |
DPBS | Gibco | 14190-144 | |
Epinephrin | Sigma-Aldrich | E4250 | |
Fetal Bovine Serum | Biowest | S181H-500 | |
Fibrinogen Human Plasma 100 mg | Sigma-Aldrich | 341576-100MG | |
Formalin | Fisher Scientific | SF100-4 | |
Formalin 4% | Formafix | 1308069 | |
FSC 22-Einbettmedium, blau | Biosystems | 3801481S | |
Hematoxylin & Eosin Solution | Sigma-Aldrich | H3136 / HT110132 | |
Lactated Ringer’s Solution 1000 mL | B Braun | R5410-01 | |
Mercedes Cannula 4mm | MicroAire | PAL-R404LL | |
NaCl 0.9% | Bbraun | 570160 | |
OCT Embedding Matrix 125 mL | CellPath | KMA-0100-00A | |
Paraformaldehyde | Fisher Scientific | 10342243 | |
PBS 1% | Sigma-Aldrich | P4474 | |
PenStrep | Sigma-Aldrich | P4333-100ML | |
Petridish 150mm | Sarstedt | 83.1803 | |
Phalloidin-iFluor 488 Reagent | Abcam | ab176753 | |
Sterile Syringe 20 mL Luer | HENKE-JECT | 5200-000V0 | |
Sterile Syringe 30 mL Luer-Lock | BD | 10521 | |
Thrombin from Human Plasma | Sigma-Aldrich | T6884-100UN | |
Tranexamic acid | Orpha Swiss | 6837093 | |
Tulipfilter 1.2 | Lencion Surgical | ATLLLL | |
Tulipfilter 1.4 | Lencion Surgical | ATLLLL |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved